Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $360.0K | $250.0K | $23.0K | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $360.0K | $250.0K | $23.0K | $0 | $0 | $0 | $0 | $0 |
| Gross margin | 100.0% | 100.0% | 100.0% | — | — | — | — | — |
| R&D | $15.8M | $0 | $55.0K | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$5.4M | −$1.1M | −$7.0M | −$2.3M | −$2.1M | −$2.7M | −$1.8M | −$1.7M |
| EBITDA | $15.2M | −$3.9M | −$22.3M | −$2.3M | −$2.1M | −$2.7M | −$1.8M | −$1.7M |
| Net income | $13.2M | −$316.0K | −$22.3M | $31.2M | $28.4M | −$31.2M | −$29.2M | −$3.5M |
| Net margin | 3659.4% | -126.4% | -96934.8% | — | — | — | — | — |
| EPS (diluted) | 1.15 | -0.03 | -2.02 | 2.82 | 2.56 | -2.81 | -2.63 | -0.31 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds HSITF.
No tracked institution reports a position in HSITF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2016-08-11 | 1-for-10reverse |
No one on the platform has traded HSITF yet.
| $4M |
| — |
| MRESInstitute of Biomedical Research Corp. | $0.00 | +8.11% | $3M | — |
| PPCBPropanc Biopharma, Inc. | $1.50 | -5.06% | $1M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.